Michael J. Detke - Net Worth and Insider Trading
Michael J. Detke Net Worth
The estimated net worth of Michael J. Detke is at least $0 dollars as of 2024-09-19. Michael J. Detke is the Chief Medical Officer of Quince Therapeutics Inc and owns about 0 shares of Quince Therapeutics Inc (QNCX) stock worth over $0. Details can be seen in Michael J. Detke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Detke has not made any transactions after 2021-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael J. Detke
Michael J. Detke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael J. Detke owns 1 companies in total, including Quince Therapeutics Inc (QNCX) .
Click here to see the complete history of Michael J. Detke’s form 4 insider trades.
Insider Ownership Summary of Michael J. Detke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-08-10 | Chief Medical Officer |
Michael J. Detke Latest Holdings Summary
Michael J. Detke currently owns a total of 1 stock. Michael J. Detke owns 0 shares of Quince Therapeutics Inc (QNCX) as of August 10, 2021, with a value of $0.
Latest Holdings of Michael J. Detke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2021-08-10 | 0 | 0.74 | 0 |
Holding Weightings of Michael J. Detke
Michael J. Detke Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael J. Detke has made a total of 2 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 10,000 shares on August 10, 2021, which brought Michael J. Detke around $1,000,000.
Insider Trading History of Michael J. Detke
- 1
Michael J. Detke Trading Performance
Michael J. Detke Ownership Network
Michael J. Detke Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Michael J. Detke is the Chief Medical Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Michael J. Detke made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Michael J. Detke Mailing Address
Above is the net worth, insider trading, and ownership report for Michael J. Detke. You might contact Michael J. Detke via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
